<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04379323</url>
  </required_header>
  <id_info>
    <org_study_id>YUWELL-YLQX202001</org_study_id>
    <nct_id>NCT04379323</nct_id>
  </id_info>
  <brief_title>Clinical Trial of YuWell YE900 Electronic Sphygmomanometer</brief_title>
  <official_title>Validation of the YuWell YE900 Medical Electronic Blood Pressure Monitor in Adults and Children According to the AAMI/ESH/ISO 81060-2:2018 Standard</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Second Hospital of Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Jiangsu Yuyue medical equipment &amp; supply Co., Ltd.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The Second Hospital of Nanjing Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the accuracy of the YuWell YE900 medical electronic
      blood pressure monitor for blood pressure measurements in adults and children according to
      the Association for the Advancement of Medical Instrumentation/European Society of
      Hypertension/International Organization for Standardization (AAMI/ESH/ISO) Universal Standard
      (ISO 81060-2:2018).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 12, 2020</start_date>
  <completion_date type="Anticipated">August 13, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 12, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood pressure measurement data</measure>
    <time_frame>30 minutes</time_frame>
    <description>Systolic Pressure and Diastolic Pressure</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">85</enrollment>
  <condition>Blood Pressure</condition>
  <arm_group>
    <arm_group_label>YuWell YE900 and mercury sphygmomanometer</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Blood Pressure Measurement with the YuWell YE900 Electronic Sphygmomanometer (YuWell YE900) and with Desk Mercury Sphygmomanometer.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>YuWell YE900 Electronic Sphygmomanometer</intervention_name>
    <description>Measurement blood pressure by YuWell YE900 Electronic Sphygmomanometer and Desk Mercury Sphygmomanometer.</description>
    <arm_group_label>YuWell YE900 and mercury sphygmomanometer</arm_group_label>
    <other_name>Desk Mercury Sphygmomanometer</other_name>
    <other_name>Blood Pressure Measurement</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. 3 Years and older (Child, Adult, Older Adult);

          2. Subjects voluntarily participate in the clinical trial and sign the informed consent.

        Exclusion Criteria:

          1. Disturbance of consciousness;

          2. Patients requiring hemodialysis;

          3. Taking anticoagulant drugs due to cardiovascular and cerebrovascular diseases;

          4. Pregnant and lactating women;

          5. Patients with cardiac arrhythmias;

          6. Other conditions that the investigator considers ineligible for clinical trial.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mingzhi Long, MD PHD</last_name>
    <role>Study Director</role>
    <affiliation>The Second Hospital of Nanjing Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Huijie Zhang, MD PHD</last_name>
    <phone>86-25-58509670</phone>
    <email>zhanghuijie@njmu.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Second Affiliated Hospital of Nanjing Medical University</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210011</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Huijie Zhang, MD PHD</last_name>
      <phone>86-25-58509670</phone>
      <email>zhanghuijie@njmu.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 4, 2020</study_first_submitted>
  <study_first_submitted_qc>May 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 7, 2020</study_first_posted>
  <last_update_submitted>May 25, 2020</last_update_submitted>
  <last_update_submitted_qc>May 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Second Hospital of Nanjing Medical University</investigator_affiliation>
    <investigator_full_name>zhang Hui Jie</investigator_full_name>
    <investigator_title>Director of Clinical trial center</investigator_title>
  </responsible_party>
  <keyword>AAMI/ESH/ISO 81060-2: 2018 standard</keyword>
  <keyword>blood pressure measurement</keyword>
  <keyword>blood pressure monitor</keyword>
  <keyword>validation study</keyword>
  <keyword>YuWell YE900</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

